FDA Import Refusal FR1-0018552-4/21/1 — Nipro Corporation
The FDA refused shipment FR1-0018552-4/21/1 from Nipro Corporation (Japan) on Aug 1, 2022. The refused product falls under Devices — CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 1, 2022
- Country
- Japan
- Product Category
- Devices
- Product Code
- 74LOX CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS & OPERATIVE
- Charges
- 118,3280